<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Article Authoring DTD v1.4 20240229//EN" "JATS-articleauthoring1.dtd">
<article article-type="research-article" xml:lang="zh-CN" xmlns:xlink="http://www.w3.org/1999/xlink">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">19</journal-id>
      <journal-title-group>
        <journal-title>医学研究</journal-title>
      </journal-title-group>
      <issn>2661-359X</issn>
      <publisher>
        <publisher-name>华文科学出版社</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.12421/yxyj2661-3603-2026-8-10-86</article-id>
      <article-id pub-id-type="publisher-id">31029</article-id>
      <title-group>
        <article-title>药物相关性颌骨坏死发病机制的研究进展</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <string-name>刘琳 陈晖通讯作者 （华北理工大学 河北唐山 063000）</string-name>
        </contrib>
      </contrib-group>
      <pub-date pub-type="epub">
        <year>2026</year>
        <month>10</month>
      </pub-date>
      <issue>10</issue>
      <abstract>
        <p>1. 引言药物相关性颌骨坏死（medication-related osteonecrosis of the jaw, MRONJ）是一种严重的药物不良反应，表现为颌骨的进行性坏死，可有骨暴露、感染、疼痛及功能障碍等伴发症状[1,2]。</p>
      </abstract>
    </article-meta>
  </front>
</article>
